Search

Search Constraints

You searched for: Author/Creator Ghiringhelli, Francois

Search Results

1. A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma. (28th September 2018)

2. Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2. (18th April 2019)

5. Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer. (September 2022)

6. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Issue 5 (18th December 2013)

7. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects. (July 2017)

8. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Issue 3 (17th May 2019)

9. Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France. Issue 5 (June 2020)

10. Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer. Issue 6 (3rd June 2021)